HPV Virus Vaccine

Human Papilloma Virus (HPV) is

one of the causative agents of cervical cancer. It is the second
most lethal cancer in women, second only to breast cancer, killing
275,000 women worldwide every year.
Therefore, a successful HPV vaccination is considered a major
medical accomplishment. The U.S. Food and Drug Administration
(FDA) has approved HPV vaccines like Gardasil and Cervarix for
use among females between 9 – 26 years of age.
The first HPV vaccine became available in 2006. As of 2017, 71
countries include it in their routine vaccinations, at least for girls.
They are on the World Health Organization's List of Essential
Medicines, the most effective and safe medicines needed in
a health system. The wholesale cost in the developing world is
about US$47 a dose as of 2014. In the United States, it costs
more than US$200.[10] Vaccination may be cost effective in
the developing world.
Discovered by: Ian Frazer and Jian Zhou at the University
of Queensland in 2006